| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2004014949A3 Gastric and colon cancer-associated antigens |
| 07/29/2004 | WO2004007668A3 Improved transporters and their uses |
| 07/29/2004 | WO2004004663A3 Compositions and methods for ligament growth and repair |
| 07/29/2004 | WO2004000873A3 Adjuvant-free peptide vaccine |
| 07/29/2004 | WO2003102148A3 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 07/29/2004 | WO2003099853A3 Petide amidation process |
| 07/29/2004 | WO2003095654A3 Method for producing a transgenic plant having modified transport of substances |
| 07/29/2004 | WO2003093313A3 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 07/29/2004 | WO2003089927A3 Antigens associated with haematological malignancy |
| 07/29/2004 | WO2003078598A3 Methods for using bag expression as a cell differentiation agent and marker |
| 07/29/2004 | WO2003077870A3 New strains of mycoplasma hyorhinis as causative agents for autoimmune disease |
| 07/29/2004 | WO2003077838A3 Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens |
| 07/29/2004 | WO2003076596A3 Altering viral tropism |
| 07/29/2004 | WO2003076464A8 Mutagenesis of aspergillus fungi and identification of genes essential for growth |
| 07/29/2004 | WO2003072744A3 Dna construct for inducible expression of angiogenic protein and use thereof |
| 07/29/2004 | WO2003072722A3 IMMUNOGENIC AVIAN HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003066833A3 Use of recombinant hepatitis b core particles to develop vaccines against infectious pathogens and malignancies |
| 07/29/2004 | WO2003060089A3 Metalloproteins |
| 07/29/2004 | WO2003060067A3 P85-alpha nucleic acids, polypeptides and related methods |
| 07/29/2004 | WO2003042235A9 Extended native chemical ligation of three or more peptide fragments |
| 07/29/2004 | WO2003040369A3 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2003018623A3 Papillomavirus proteins and pharmaceutical compositions |
| 07/29/2004 | WO2003011209A3 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 07/29/2004 | WO2002094994A3 Chimeric antigen-specific t cell-activating polypeptides |
| 07/29/2004 | WO2002068608A3 Sulfated ccr5 peptides for hiv-1 infection |
| 07/29/2004 | US20040148666 Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof |
| 07/29/2004 | US20040148658 Phosphatase stress-related proteins and methods of use in plants |
| 07/29/2004 | US20040148655 of a brassinosteroids (BRs) biosynthetic locus, designated dwarfs (dwf5), each of which contain loss-of-function mutations in the sterol Delta 7 reductase gene; in vivo/vitro cultures |
| 07/29/2004 | US20040148654 for increasing yield in plants, particularly seed plants and protecting against environmental stress (drought, cold); genetic engineering |
| 07/29/2004 | US20040148652 for producing stable dwarf crop plants with disease resistance; agriculture/horticulture; genetic engineering |
| 07/29/2004 | US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor |
| 07/29/2004 | US20040148149 Molecular modeling for metalloproteins |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147734 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics |
| 07/29/2004 | US20040147733 for diagnosis/therapy for immune system-related disorders; drug screening; genetic engineering |
| 07/29/2004 | US20040147732 Novel human G-protein coupled receptor, HGPRBMY9, expressed highly in brain and testes |
| 07/29/2004 | US20040147731 Polynucleotides and polypeptides relating to the modulation of sirp alpha-cd47 |
| 07/29/2004 | US20040147727 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/29/2004 | US20040147726 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147723 Moringa seed proteins |
| 07/29/2004 | US20040147722 Novel secreted proteins |
| 07/29/2004 | US20040147721 Antigens and vectors for vaccination |
| 07/29/2004 | US20040147720 Novel guasonine triphosphate-binding protein -coupled receptor place 6002312, its gene and production and use of the same |
| 07/29/2004 | US20040147719 Type III bacterial strains for use in medicine |
| 07/29/2004 | US20040147718 Nucleotide and protein sequences of lats genes and methods based thereon |
| 07/29/2004 | US20040147474 For use as vaccines against bacterial infections, diagnosis, prophylactic and therapeutic uses. |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147467 For producing an immune response in fish |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147448 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 07/29/2004 | US20040147447 For therapy of cancer or autoimmune diseases |
| 07/29/2004 | US20040147444 Use of a fusion protein comprising a latency associated peptide and a proteolytic cleavage site for providing latency to a pharmaceutically active agent |
| 07/29/2004 | US20040147442 Thrombin-inhibiting peptides |
| 07/29/2004 | US20040147437 Calycins |
| 07/29/2004 | US20040147436 For therapy of Hemophilia A |
| 07/29/2004 | US20040147435 Compositions and methods for importing biologically active molecules into cells and for treating inflammation |
| 07/29/2004 | US20040147432 Melanin-concentrating hormone analogs |
| 07/29/2004 | US20040147431 Erythropoietin composition |
| 07/29/2004 | US20040147429 Endogenous, constitutively activated G protein-coupled orphan receptors |
| 07/29/2004 | US20040147006 Amino acid sequences comprising nuclear localization signal petides for use as enzyme inhibitors in treatment of viral and nervous system disorders; gene therapy and mimetics |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040147000 Enhancing yield of aromatic carboxylic acids in enteric bacteria via transforming, propagating and fermentation with operon coding transport protein |
| 07/29/2004 | US20040146991 Identifying modulator of activation inducible lymphocyte immunomodulatory molecule (AILIM) for use in suppressing, preventing and/or treating inflammatory, autoimmune and allergic disorders |
| 07/29/2004 | US20040146990 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 07/29/2004 | US20040146989 Nucleotide sequences coding cytokine fusion protein for use in the prevention and treatment of tumor and viral infections |
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146985 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 07/29/2004 | US20040146983 Enhanced production of Streptococcus mutans mutacin I and III |
| 07/29/2004 | US20040146982 hKIS compositions and methods of use |
| 07/29/2004 | US20040146979 Growth/differentiation factor of the TGF-beta family |
| 07/29/2004 | US20040146978 Isolated human Ras-like proteins, nucleic acid molecules encoding human Ras-like proteins, and uses thereof |
| 07/29/2004 | US20040146974 Method for producing L-amino acid using methylotroph |
| 07/29/2004 | US20040146973 Human acid-sensing ion channel 2b (hASIC2b) |
| 07/29/2004 | US20040146972 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/29/2004 | US20040146971 Novel p53 inducible protein |
| 07/29/2004 | US20040146970 Proteins associated with cell growth, differentiation, and death |
| 07/29/2004 | US20040146968 Three dimensional structure of human derived apoptotic factor and receptor thereof x-ray crystallography and trail deletion mutant protein |
| 07/29/2004 | US20040146967 Novel g protein-coupled receptor protein and dna thereof |
| 07/29/2004 | US20040146966 Mutations affecting carotenoid production |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146963 High throughput assays for the proteotytic activities of clostridial neurotoxins |
| 07/29/2004 | US20040146954 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 07/29/2004 | US20040146952 T cell receptors mutants that have higher affinity for the peptide/MHC ligand than the wild type; can be used in place of an antibody or single chain antibody |
| 07/29/2004 | US20040146948 single-chain variable region fragment (scFv) comprising a heavy chain variable region (VH) operably linked to a light chain variable region (VL); for cancer treatment |
| 07/29/2004 | US20040146935 Disease associated gene |
| 07/29/2004 | US20040146932 for detecting, diagnosing, and treating prostate cancer and for measuring hormone responsiveness of prostate cancer cells; genetic engineering |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146928 Human neuronal attachment factor-1 |
| 07/29/2004 | US20040146927 Fibroblast growth factor-14 |
| 07/29/2004 | US20040146926 Chemokine receptor |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146914 comprising bromodomains and the encoding gene; for anticancer agents; genetic engineering |
| 07/29/2004 | US20040146908 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 07/29/2004 | US20040146906 Novel PTH responsive gene |